Free Trial
CVE:NVV

Norvista Capital (NVV) Stock Price, News & Analysis

C$0.08 -0.01 (-6.25%)
As of 01/12/2022

About Norvista Capital Stock (CVE:NVV)

Key Stats

Today's Range
C$0.08
C$0.08
50-Day Range
C$0.08
C$0.08
52-Week Range
C$0.07
C$0.23
Volume
112,500 shs
Average Volume
116,000 shs
Market Capitalization
C$5.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NVV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Norvista Capital and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVV Stock News Headlines

REVEALED: Something Big Happening Behind White House Doors
What I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
See More Headlines

NVV Stock Analysis - Frequently Asked Questions

Norvista Capital's stock was trading at C$0.08 at the beginning of 2025. Since then, NVV stock has increased by 0.0% and is now trading at C$0.08.

Shares of NVV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Norvista Capital investors own include Matinas Biopharma (MTNB), Advanced Micro Devices (AMD), Altimmune (ALT), Albireo Pharma (ALBO), Alliance Data Systems (ADS), AcelRx Pharmaceuticals (ACRX) and Albertsons Companies (ACI).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Industrial Metals & Minerals
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:NVV
CIK
N/A
Fax
N/A
Employees
1,990
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.07
Current Ratio
11.62
Quick Ratio
11.58

Sales & Book Value

Annual Sales
-C$1.27 million
Price / Sales
-4.13
Cash Flow
C$0.12 per share
Price / Cash Flow
0.63
Book Value
C$0.11 per share
Price / Book
0.67

Miscellaneous

Outstanding Shares
70,141,000
Free Float
N/A
Market Cap
C$5.26 million
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (CVE:NVV) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners